研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

ISTH 2023年大会的最新进展胶囊图解。

Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress.

发表日期:2023 May
作者: Susan R Kahn, Donald M Arnold, Caterina Casari, Karl C Desch, Katrien M J Devreese, Emmanuel J Favaloro, Florian Gaertner, Samantha C Gouw, Paolo Gresele, Arjan W Griffioen, Lukas Heger, R Manjunatha Kini, Shrey Kohli, Avi Leader, Ton Lisman, Marie Lordkipanidzé, Eric Mullins, Helen Chioma Okoye, Rachel P Rosovsky, Isabelle I Salles-Crawley, Rita Selby, Michelle Sholzberg, David Stegner, Francesco Violi, Angela C Weyand, Suzan Williams, Ze Zheng
来源: Research and Practice in Thrombosis and Haemostasis

摘要:

2023年的国际血栓与止血学会(ISTH)大会于2023年6月24日至28日在加拿大蒙特利尔举行。这次年度会议突出了与学会相关的基础科学、翻译研究、人群科学和临床科学的尖端进展。与所有ISTH大会一样,我们提供了一个特别的、大会专属的科学主题;今年的特别主题是免疫性血栓形成。在过去几年里,COVID-19感染及其相关的血栓和其他并发症重新引起了人们对血栓炎和免疫性血栓形成概念的兴趣;即炎症、感染与凝血之间的关系。大会的其他主要科学主题包括动脉血栓栓塞、凝血与天然抗凝血剂、诊断与组学、纤溶与蛋白酶解、血友病和罕见出血性疾患、癌症中的止血系统、炎症与免疫、儿科、血小板疾病、Von Willebrand病和血栓性微血管病、血小板和巨核细胞、血管生物学、静脉血栓栓塞和妇女健康。除其他会议之外,大会还包括了28个最新进展报告(SOA)主题,并由国际知名领导者发表了84个演讲。SOA演讲者被邀请准备他们演讲的简明图解评论,并通过同行评审,包含在本文中。这些图解评论突出了具有潜在影响临床实践的重要科学进展。读者被邀请利用这些图解评论提供的优秀教育资源。也鼓励他们在社交媒体上使用这些图片,以引起对大会所呈现的高品质和影响力的关注。© 2023由爱思唯尔公司代表国际血栓与止血学会出版。
This year's Congress of the International Society of Thrombosis and Haemostasis (ISTH) took place in person in Montréal, Canada, from June 24-28, 2023. The conference, held annually, highlighted cutting-edge advances in basic, translational, population and clinical sciences relevant to the Society. As for all ISTH congresses, we offered a special, congress-specific scientific theme; this year, the special theme was immunothrombosis. Certainly, over the last few years, COVID-19 infection and its related thrombotic and other complications have renewed interest in the concepts of thromboinflammation and immunothrombosis; namely, the relationship between inflammation, infection and clotting. Other main scientific themes of the Congress included Arterial Thromboembolism, Coagulation and Natural Anticoagulants, Diagnostics and Omics, Fibrinolysis and Proteolysis, Hemophilia and Rare Bleeding Disorders, Hemostatic System in Cancer, Inflammation and Immunity, Pediatrics, Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies, Platelets and Megakaryocytes, Vascular Biology, Venous Thromboembolism and Women's Health. Among other sessions, the program included 28 State-of-the-Art (SOA) sessions with a total of 84 talks given by internationally recognized leaders in the field. SOA speakers were invited to prepare brief illustrated reviews of their talks that were peer reviewed and are included in this article. These illustrated capsules highlight the major scientific advances with potential to impact clinical practice. Readers are invited to take advantage of the excellent educational resource provided by these illustrated capsules. They are also encouraged to use the image in social media to draw attention to the high quality and impact of the science presented at the Congress.© 2023 Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.